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Introduction
In physiological conditions, within components of the
enteric nervous system supplying the human large
intestine, the presence of the following neuropeptides
has been found: vasoactive intestinal peptide (VIP),
neuropeptide Y (NPY) and pituitary adenylate cyclase-
activating polypeptide (PACAP) [1-5]. It is known that
these neuropeptides are neurotransmitters and neuro-
modulators of the enteric nervous system. The VIP-
ergic neurons of the submucosal plexuses have influ-
ence of intestinal secretions and VIP-ergic neurons of
the myenteric plexuses cause relaxation of the intestine
[6]. It has also been shown that PACAP is a neuro-
transmitter suppressing the contraction of the intestin-
al muscle, and in the region of the mucous membrane
it cause increases of intestinal secretion [7]. It is also
known that NPY inhibits contraction of the intestinal
muscle, probably by suppressing the cholinergic trans-
mission and also in the intestinal wall there are post-
ganglionic nerve fibres containing NPY which inner-
vate the submucosal arterioles, producing their con-
striction [8-10]. Investigations of the enteric nervous
system in inflammatory diseases of the large intestine
have shown morphological changes in this system.
These changes are mostly related with increase, or
decrease the number of neurons and density of nerve
fibres containing neuropeptides [11-16].
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As yet there is no data in the literature dealing with
the problem of changes in the innervation of human
organs affected by cancer. The presence of nerve fibres
containing GAL, SP and NPY has been confirmed
only in cancerous tumour of the esophagus and stom-
ach cardia [17]. The only publication presenting
changes in the density of nerve fibres in the circular
muscle of the large intestine was based on studies on
laboratory animals with colon cancer [18].
The study of the innervation of human colon cancer
were concerned with analysis of the innervation of
blood vessels adjacent to the tumour [19]. Similar
observations have been made concerning the colorectal
liver metastases, and the presence of this innervation
were not observed [20]. It seems that a description of
characteristics of morphological changes in the nervous
system supplying the large intestine wall in patients
with carcinoma of the sigmoid colon and rectum may
contribute to mechanism of the symptoms from which
the patients are suffering. In view of the points present-
ed above it was decided that this study should deal with
localisation and morphological comparison of VIP-
ergic, PACAP-ergic and NPY-ergic neurons and nerve
fibres of the enteric nervous system in the wall of the
sigmoid colon and rectum with cancerous tumour,
between normal and pathologically changed tissues.
Material and methods
Tissue samples. Samples for this study were taken from postoper-
ative material originating from patients undergoing operations for
carcinoma of the large intestine. Material was collected from 15
patients (nine women and six men), of the average age 63.0 years,
(range 41-78). Patients in a generally good state of health were
qualified for the study, had no evidence of bowel obstruction or
other colonic disease. Patients undergoing pre-operative radiother-
apy were excluded. 
Immunohistochemistry. Two small samples comprising all layers
of the intestine wall were taken from the post-operative material.
One sample was taken from the macroscopically unchanged part of
the intestine at a minimum distance of 5 cm from the tumour; the
second one was taken from the margin of the tumour. The samples
were fixed for two hours in 4% buffered paraformaldehyde solu-
tion, rinsed for 24 hours in phosphate buffer and stored in 18%
buffered sucrose solution until further processing. Cryostat sec-
tions (10 μm) were double-labelled immunohistochemically as
described previously [21] for protein gene product-9.5 (PGP-9,5),
a marker of nerve structures, and for one of the neuropeptides
under study (Table 1). 
The labelled sections were studied using a fluorescent micro-
scope (Axiophot Zeiss) and a confocal laser microscope (Bio-Rad
Microradiance MR2) equipped with epiillumination and appropri-
ate filter set for fluorescein isothiocyanate (FITC) or Texas Red.
Expression of two fluorescent levels was examined by interchang-
ing filters. The images were scanned and then superimposed using
appropriate programs (LaserSharp 2000 v. 3.1, Bio-Rad; LaserPix
v. 4.0013 Media, Cybernetics L.P.)
A preabsorbtion test was carried out to study the specifity of
antisera used and no staining was observed in control sections
incubated with antisera preabsorbed with corresponding peptides.
Additional negative controls involved the omission and replace-
ment of all primary antisera by non-immune sera.
The number of neurons containing particular examinated sub-
stances in the sections from cancer tissues and in the control sec-
tions was determined. In this purpose, the number of neurons pres-
ent in particular plexuses in sections of each part of the intestine
was counted. Neurons containing particular labelled neuropeptides
were counted in amount at least 400 positive PGP-9.5 neurons.
An analysis of the number of nerve fibres was also carried out.
Approximate quantites were assessed using the following scale: 
0 – no fibres, ( +) low density of fibres, (++) medium density of
fibres, (+++) high density of fibres. 
On the basis of initial microscopic observations, only sections
were examinated in which the neoplastic tissues were observed and
cancerous tumor destroyed the mucous membrane and the submu-
cous tissue. In these sections, the submucous plexuses were visible
and the linear structure of the myenteric plexuses was preserved.
Ethical issues. The study was approved by Local Bioethical Com-
mission permit No. 107/2004/II, Warmia and Mazury District
Medical Association, Poland.
Statistical analysis. The data obtained were statistically analysed
with the Mann and Whitney nonparametric U-test. Comparison of
the density of the nerve fibres in the plexuses in the control and
pathological sections was carried out using the Kendall τ rank cor-
relation coefficient [22,23].
Table 1. List of primary antibodies and secondary reagents used in this study.
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Results
The statistical analysis of the present study allowed to
resume potential changes in number of neurons and
density of nerves fibres containing particular neu-
ropeptides. Comparison of mean percentage of NPY-
ergic neurons in the submucosus plexuses in patholog-
ical sections with mean percentage of appreciate neu-
rons in control sections showed statistical significant
difference (p≤0.05) in presence of two investigated
group of neurons. A decrease from 36.92% to 16.58%
of mean percentage of NPY-ergic neurons in the sub-
mucosus plexuses was noted.
However, the statistically similar mean percentage
of VIP-ergic neurons, 56.82% and 51.01%, as well as
PACAP-ergic neurons, 45.61 and 36.70%, respectively
in the submucosus plexuses was observed. In the myen-
teric plexus, the statistical significant reduction of
mean percentage of NPY-ergic neurons was from
42.09% in control sections to 25.20% in pathological
sections. Changes of mean percentage of VIP-ergic
neurons in the myenteric plexus was statistical insignif-
icant, 36.68% to 43.82%, respectively. Mean percent-
age of PACAP-ergic neurons was similar, 32.61% to
29.86% in compared groups respectively. The changes
in density of nerve fibres containing investigated neu-
ropeptides in both submucosus and the myenteric
plexuses were more considerable than the presented
above changes of mean percentages of the neurons. A
significant decrease in density of PACAP-ergic and
NPY-ergic nerve fibres was founded in pathological
sections in submucosus and myenteric plexuses respec-
tively and VIP-ergic nerve fibres in the myenteric
plexus. However, a decrease density in the number of
the VIP-ergic nerve fibres in submucosus plexuses of
pathological sections was observed but statistically
insignificant. (Tables 2 and 3, Fig. 5 and 6).
Discussion
The results of this study provide evidence of enteric
nervous system state in colon cancer invasion.
Changes in neurons and nerve fibres containing inves-
tigated neuropeptides located close to cancer tissue
were observed. These changes and lack of neural ele-
ments in solid cancer tissue may suggest dysfunction
of innervation of this and impair part of the colon. It
also may caused disruption of proper colon function
and may be responsible for some of symptoms due
with colorectal cancer invasion.
Anatomical studies on the regular innervation of the
intestine in humans have revealed the presence of VIP-
ergic neurons in submucous plexuses and myenteric
plexuses of the small and large intestine [2-4,24]. Sim-
ilar studies carried out on animals have shown also the
presence of VIP-ergic neurons in both the small and in
the large intestine [25-28]. As mentioned previously,
studies on the enteric nervous system of the large intes-
tine with cancer were performed only in relation to
changes in the number of neurons and nerve fibres con-
taining VIP in the large intestine of the rat. In these
studies, an increase in the density of VIP-ergic fibres in
myenteric plexuses of the large intestine with cancer in
comparison to the control material has been observed
[18]. Studies published so far dealing with changes in
the enteric nervous system of the human large intestine
were related to other pathological states, mostly inflam-
matory processes. It has appeared that the results of
these studies are often contradictory. Studies relating to
Crohn's disease shoud be mentioned, and in this disease
Table 3. Percentage of VIP, PACAP and NPY- ergic neurons found in the myenteric plexus in control and pathological sections.
Table 2. Percentage of VIP, PACAP and NPY- ergic neurons found in the submucous plexus in control and pathological sections.
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Fig. 1. The myenteric plexus (MP) in a control section. Confocal laser scaning microscope (CLSM) image showing neurons expressing
PGP-9.5 (b) and VIP (c). These images were superimposed (a), double labelled (PGP-9.5 and VIP-positive) neurons are yellow. Numer-
ous neurons are visible (arrows) and a dense network of nerve fibres (spearheads) is present. The majority of the neurons and nerve fibres
in this plexus were VIP-positive. Bar=60 μm.
Fig. 2. The myenteric plexus (MP) in a pathological section. CLSM image showing the distribution of neurons expressing PGP-9.5 (b)
and VIP (c). These images were superimposed (a), double labelled (PGP-9.5 and VIP-positive) neurons are yellow. Neurons (arrows) and
nerve fibres (spearheads) in the MP. The majority of the neurons are VIP-positive; the nerve fibres are of medium density. The difference
in size (smaller) and shape of neurons in this plexus in comparison to that shown above (a) is noticeable. The distribution of the nerve
fibres is also different in this pathological sections. Bar=60 µm.
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Fig. 3. The inner submucosal plexus (ISP) in a control section. CLSM image showing the distribution of neurons expressing PGP-9.5 (b)
and PACAP (c). These images were superimposed (a), double labelled (PGP-9.5 and PACAP-positive) neurons are yellow. Perikarya
(arrow) and nerve fibres (spearheads) are visible and form ISP. Bar=60 µm.
Fig. 4. The inner submucosal plexus (ISP) in a pathological section. CLSM image showing the distribution of neurons expressing PGP-
9.5 (b) and PACAP (c). These images were superimposed (a), double labelled (PGP-9.5 and PACAP-positive) neurons are yellow. Neu-
rons (arrows) are visible in the ISP. The majority of the neurons were PACAP-positive (arrows). Note the small number of nerve fibres
in this plexus. Bar=60 µm. 
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there is an increase in the density of nerve elements
containing VIP in the wall of the small and the large
intestine [11,13]. On the other hand, observations relat-
ed to the same disease suggest that there are no similar
changes in the density of nerve elements containing
VIP in the layers of the intestinal wall [29]. Results of
other studies on Crohn's disease are completely differ-
ent. A reduction in VIP-ergic nerve fibres and VIP con-
centrations has also been observed in ulcerative colitis
[12,30]. Post radiation changes of the large intestine,
after neoadjuvant radiotherapy, consist of, among oth-
ers, a decrease, in the number of VIP-ergic nerve fibres
in the wall of the intestine [31]. Experimental studies
carried out on animals confirm the existence of changes
in the innervation of the large intestine during inflam-
mation processes. In experimental infection of pigs
with the Schistosoma japonicum parasite, a reduction in
the number of neurons and the density of VIP-contain-
ing nerve fibres in the large intestine was found. This
reduction in VIP-ergic elements, to the point where
they were completely absent, was accompanied by
necrotic and degenerative changes in the wall of the
large intestine [32]. Analysis of changes in the number
of VIP-ergic nerve elements is difficult due to the dif-
ferent phasing of the state of inflammation of the intes-
tine. The earlier fall in the number of VIP-positive
nerve fibres in the large intestinal wall of the rat, and
next a later increase in their number have been
observed [33]. The data given above indicate that the
problem dealing with changes in the quantity of VIP in
Fig. 5. Changes in the density of nerve
fibers in submucous plexuses in con-
trol and pathological sections.
Fig. 6. Changes in the density of nerve
fibers in myenteric plexuses in control
and pathological sections.
nerve elements supplying the large intestinal wall in
various pathological states has not been definitively
resolved; in this connection, there is also a lack of data
relating to changes in the number of VIP-ergic nerve
elements in the human intestine undergoing neoplasmal
processes. In the present study, the changes of the num-
ber VIP-ergic neurons were observed, but these differ-
ences were statistically insignificant in the pathological
material in comparison to the control tissues. On the
other hand a significant decrease was observed in the
density of VIP-ergic nerve fibres in the myenteric
plexuses in the pathological material. Taking into con-
siderations the fact that the data in the literature are
often contradictory, interpretation of the present results
is not easy. The decrease, statistically insignificant, in
the number of VIP-ergic neurons in submucous plexus-
es in the cancerous tumour is certainly brought about
by the damage to the intestinal wall caused by the
tumour. The results of this study indicates that the sub-
mucous plexuses are more sensitive to the destruction
with pathological processes, what was previously
described [32]. Similar results of studies on the
decrease in the density of VIP-ergic nerve fibres have
been observed in radiation damage in the human intes-
tine [31]. The reduction in the density of VIP-ergic
nerve fibres in pathological material in the myenteric
plexuses, as shown in this study, may indicate damage
by the tumour to the innervation responsible for dias-
tole of the intestine. The results of this study are not in
agreement with the results of studies on inflammatory
states of the intestine in humans, where an increase in
the number of neurons and VIP-ergic nerve fibres has
been observed [11,13]. This contradiction may indicate
that the mechanism for initiation and development of
inflammatory and neoplasmal processes are signifi-
cantly different. In the diseases mentioned above, the
state of inflammation was acute and present in a large
part, or the whole of the intestine. It is also probable
that the reaction mechanism of the enteric nervous sys-
tem in the course of cancer is different.
The presence of numerous neurons and PACAP-
ergic nerve fibres in submucous plexuses and in the
myenteric plexuses of the large intestine wall has been
observed in humans and laboratory animals. These
neurons have been described as inhibitory motor neu-
rons, suppressing muscular relaxation, and as choliner-
gic and non-cholinergic interneurons [5,10,34,35].
There is no dates in the literature reporting changes in
PACAP-ergic nervous system in the course of cancer
of the large intestine in humans. There are also no such
studies on animals. The only relevant published study
concerns the innervation of the small intestine in
Crohn's disease. In this disease, an increase in the
number of neurons and the density of PACAP-ergic
nerve fibres in myenteric plexuses of the intestine is
found [13]. In the present study, a (statistically
insignificant) decrease in the number of neurons in
both the submucous and myenteric plexuses in relation
to the corresponding plexuses in the control tissues has
been noted. A significant reduction in the density of
nerve fibres in both the submucous and myenteric
plexuses of the large intestine was observed in the
pathological tissues. The results obtained in this study
does not corroborate findings of other studies which
have reported an increase in PACAP-ergic elements in
the enteric nervous system of the small intestine in
Crohn's disease. In these studies, an increase in the
number of neurons and PACAP-ergic nerve fibres was
apparently connected with the interaction between the
enteric nervous system and the immunological system,
in inflammatory diseases of the intestine. The present
results showing a reduction in the number of PACAP-
ergic neurons may indicate an impairment of relax-
ation and decreased secretion in the affected part of the
intestine.
There are few studies describing NPY-ergic inner-
vation of the human large intestine wall. The presence
of NPY-ergic neurons has been found in the myenteric
plexus and the presence of a small number of NPY-
ergic nerve fibres has also been observed in the in the
submucous and the myenteric plexuses [1,2,4,36].
NPY-ergic innervation in animals is better recognised.
The presence of NPY-ergic neurons in the region of the
submucous plexuses has been confirmed and these
nerve cells have been classified as interneurons and
cholinergic secretomotoric neurons. Also NPY is pres-
ent in postganglionic cholinergic vasoconstrictor
nerves. Inhibitory motor neurons and cholinergic
interneurons have been located in the myenteric plexus
in both the small and large intestine of the guinea pig
[10,27,37,38].
Studies published so far have shown a lack of
changes in NPY-ergic innervation of the large intes-
tine wall in humans in such pathological conditions
as: diverticulosis and idiopathic constipation [2,39].
On the other hand, some changes have been observed
in Crohn's disease; these changes consist of an
increase in the number of NPY-ergic neurons and
density of NPY-ergic nerve fibres in the myenteric
plexus of the small intestine [13]. In the present
study, statistically significant reductions in the num-
ber of neurons in submucous and myenteric plexuses
in pathological sections as compared to such plexus-
es in the control material were found. A decrease in
the density of NPY-positive nerve fibres in both sub-
mucous and myenteric plexuses in the pathological
material was also observed, which indicates a sub-
stantial damage caused by the cancerous tumour to
the NPY-ergic parts of the innervation of the large
intestine. Results of other studies, as mentioned
above, which have shown a lack of changes in NPY-
ergic innervation in other pathologies of the intestine,
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such as diverticulosis, idiopathic constipation or
post-radiation enteropathy, or which have revealed an
increase in the number of such elements in the small
intestine in Crohn's disease, differ from those of the
present study. It may be assumed, that significant
changes, as observed in this study, in NPY-ergic
innervation – which, in the normal state of the intes-
tine produces diastole of the intestinal wall – may
cause an increased contraction of the part of the large
intestine affected by cancer.
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